Literature DB >> 314605

Cerebellar stimulation in the management of cerebral palsy: clinical and physiological studies.

P K Wong, H J Hoffman, A B Froese, L J Platt, S Blacha, J Gear.   

Abstract

Cerebellar stimulators were inserted into seven children who had cerebral palsy and in whom extensive investigation, including computerized tomography, had revealed no structural brain abnormality. A team including physiotherapists, occupational therapists, speech pathologists, and respiratory physiologists assessed the children pre- and postoperatively; their somatosensory evoked potentials were also measured. The mean age at implantation was 8.6 yearsl follow-up has ranged from 8 to 23 months (mean, 17.3 months). No adverse effects of the cerebellar stimulation have been noted. Detailed case histories obtained from the parents, together with formal assessment scores, indicate good improvement in six patients and mild but significant improvement in the seventh. Clinically, there has been gradual improvement in all seven patients. The charge density range associated with clinical improvement was 0.8 to 2.1 muCi/cm2/phase. The stimulation equipment must be monitored very carefully to ensure that any variation from the desired output is acceptably small because it is probable that sizable deviation is a determining factor in lack of response to this therapy.

Entities:  

Mesh:

Year:  1979        PMID: 314605     DOI: 10.1227/00006123-197908000-00004

Source DB:  PubMed          Journal:  Neurosurgery        ISSN: 0148-396X            Impact factor:   4.654


  2 in total

1.  Correlation of ultrasound imaging of oral swallow with ventilatory alterations in cerebral palsied and normal children: preliminary observations.

Authors:  D J Kenny; M J Casas; K A McPherson
Journal:  Dysphagia       Date:  1989       Impact factor: 3.438

2.  Swallowing/ventilation interactions during oral swallow in normal children and children with cerebral palsy.

Authors:  M J Casas; D J Kenny; K A McPherson
Journal:  Dysphagia       Date:  1994       Impact factor: 3.438

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.